Literature DB >> 27048230

Kidney retransplantation in children following rejection and recurrent disease.

Rebecca C Graves1, Richard N Fine2,3.   

Abstract

Retransplantation accounts for approximately 15 % of the annual transplants performed in the USA, and in the recent International Collaborative Transplant Study report on pediatric patients 15.2 % of the 9209 patients included in the report were retransplant recipients. Although the significant advances in clinical management and newer immunosuppressive agents have had a significant impact on improving short-term allograft function, it is apparent that long-term allograft function remains suboptimal. Therefore, it is likely that the majority of pediatric renal allograft recipients will require one or more retransplants during their lifetime. Unfortunately, a second or subsequent graft in pediatric recipients has inferior long-term graft survival rates compared to initial grafts, with decreasing rates with each subsequent graft. Multiple issues influence the outcome of retransplantation, with the most significant being the cause of the prior transplant failure. Non-adherence-associated graft loss poses unresolved ethical issues that may impact access to retransplantation. Graft nephrectomy prior to retransplantation may benefit selected patients, but the impact of an in situ failed graft on the development of panel-reactive antibodies remains to be definitively determined. It is important that these and other factors discussed in this review be taken into consideration during the counseling of families on the optimal approach for their child who requires a retransplant.

Entities:  

Keywords:  Biomarkers; Graft failure; Nephrectomy; Non-adherence; Outcomes; Pediatric; Recurrence; Retransplantation

Mesh:

Year:  2016        PMID: 27048230     DOI: 10.1007/s00467-016-3346-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  47 in total

1.  Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation.

Authors:  Vincent Audard; Nassim Kamar; Dil Sahali; Isabelle Cardeau-Desangles; Sébastien Homs; Philippe Remy; Jessie Aouizerate; Marie Matignon; Lionel Rostaing; Philippe Lang; Philippe Grimbert
Journal:  Transpl Int       Date:  2012-03-13       Impact factor: 3.782

2.  Practice patterns and outcomes in retransplantation among pediatric kidney transplant recipients.

Authors:  Kyle J Van Arendonk; Jacqueline M Garonzik Wang; Neha A Deshpande; Nathan T James; Jodi M Smith; Robert A Montgomery; Paul M Colombani; Dorry L Segev
Journal:  Transplantation       Date:  2013-06-15       Impact factor: 4.939

Review 3.  Donor-specific antibodies adversely affect kidney allograft outcomes.

Authors:  Sumit Mohan; Amudha Palanisamy; Demetra Tsapepas; Bekir Tanriover; R John Crew; Geoffrey Dube; Lloyd E Ratner; David J Cohen; Jai Radhakrishnan
Journal:  J Am Soc Nephrol       Date:  2012-11-15       Impact factor: 10.121

4.  Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies.

Authors:  J A McCaughan; D M O'Rourke; A E Courtney
Journal:  Am J Transplant       Date:  2012-01-10       Impact factor: 8.086

5.  Current kidney allocation rules and their impact on a pediatric transplant center.

Authors:  E C Abraham; A C Wilson; J Goebel
Journal:  Am J Transplant       Date:  2009-02       Impact factor: 8.086

6.  Disparities in policies, practices and rates of pediatric kidney transplantation in Europe.

Authors:  J Harambat; K J van Stralen; F Schaefer; R Grenda; A Jankauskiene; M Kostic; M-A Macher; H Maxwell; Z Puretic; A Raes; J Rubik; S S Sørensen; U Toots; R Topaloglu; B Tönshoff; E Verrina; K J Jager
Journal:  Am J Transplant       Date:  2013-05-29       Impact factor: 8.086

7.  Inhibition of the mTORC pathway in the antiphospholipid syndrome.

Authors:  Guillaume Canaud; Frank Bienaimé; Fanny Tabarin; Guillaume Bataillon; Danielle Seilhean; Laure-Hélène Noël; Marie-Agnès Dragon-Durey; Renaud Snanoudj; Gérard Friedlander; Lise Halbwachs-Mecarelli; Christophe Legendre; Fabiola Terzi
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

Review 8.  Retransplantation in Alport post-transplant anti-GBM disease.

Authors:  Gemma Browne; Paul A J Brown; Charles R V Tomson; Stewart Fleming; Andrew Allen; Richard Herriot; Charles D Pusey; Andrew J Rees; A Neil Turner
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

9.  BK polyomavirus in solid organ transplantation.

Authors:  H H Hirsch; P Randhawa
Journal:  Am J Transplant       Date:  2013-03       Impact factor: 8.086

Review 10.  Congenital nephrotic syndrome and recurrence of proteinuria after renal transplantation.

Authors:  Christer Holmberg; Hannu Jalanko
Journal:  Pediatr Nephrol       Date:  2014-03-29       Impact factor: 3.714

View more
  1 in total

1.  Organ Transplant Recipients' Experiences of Physical Activity: Health, Self-Care, and Transliminality.

Authors:  Gareth Wiltshire; Nicola J Clarke; Cassandra Phoenix; Carl Bescoby
Journal:  Qual Health Res       Date:  2020-10-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.